BioActor

Netherlands
Maastricht, Limburg, The Netherlands, 6229

Company profile

BioActor company profile

BioActor develops proprietary health ingredients for use in functional foods, medical nutrition and dietary supplements. All these ingredients address chronic health concerns, such as diabetes,osteoporosis, cardiovascular disease, that would benefit from preventative measures through the diet. BioActor's product development strategy relies on three simple tenets: a new health ingredient must be based on a patentable scientific discovery; it must be food grade from a natural and renewable source; and its health effect must be clinically proven. BioActor's first product, BONOLIVE, a first in class bone health ingredient that is clinically proven to stimulate bone producing cells, is a great example of this strategy and will be launched in the USA this year. BioActor successfully implemented its product development strategy by establishing alliances with top nutrition research institutes (e.g. INRA, CSIC, Maastricht University, UCL, Ghent University) and by establishing production partnerships with industrial players to shorten the path to market.

Business identity

Contact email
[email protected]
Phone number
+31 43 388 5899
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2005-01-01, Year

Headquarters

Postal code
6229
Country code
NL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$2.9M
Last funding
Series A / $2.9M / 2011-07-26
Last equity funding
Series A / $2.9M
Investors
4
Lead investors
1
Founders
1

Founders and investors

Founders

Hans van der Saag

Lead investors

ICOS Capital Management

Investors

Hans van der SaagICOS Capital ManagementLimburg VenturesNedermaas Hightech Ventures